"Break the chain": Review of administrative and health systems response to the COVID-19 pandemic by India's tropical state of KeralaPoster ExhibitionE51
LBPEA01 Long-acting starch nanoparticle drug delivery system to treat chronic HIVPoster ExhibitionA22
LBPEA02 Drug resistance to novel non-nucleoside reverse transcriptase inhibitor Elsulfavirine among drug naïve HIV-infected Caucasian and Asian patientsPoster ExhibitionA3
LBPEA03 Vpu inhibitor BIT225 alters T cell activation and homing plasma membrane receptor expression on CD4+T cells (CD28 and CCR7) and monocyte-derived macrophages (CD80 and CD86)Poster ExhibitionA22
LBPEA04 Novel Gag and Envelope detection assay reveals viral and cellular dynamics during early treatment periods at the single-cell levelPoster ExhibitionA16
LBPEA05 Characterising the serum metabolic profile of HIV/TB co-infectionPoster ExhibitionA30
LBPEA06 Reanalysis of native RNA sequencing of HIV-1 supports spliced HIV mRNA packaging into virions as a new hybrid segmented retrovirus modelPoster ExhibitionA2
LBPEB07 A randomized prospective study evaluating virologic outcomes among patients switching with detectable and undetectable viral loads from efavirenz and nevirapine-based first line ART regimens to DTG regimens in ZambiaPoster ExhibitionB32
LBPEB08 Half of children living with HIV with virologic failure have drug resistance requiring antiretroviral regimen change: early insights from a randomized trial in western KenyaPoster ExhibitionB51
LBPEB09 Comparative outcomes in hospital admissions with COVID-19 in people living with HIV and people living without HIV: A retrospective studyPoster ExhibitionB69